Abstract
The use of amniotic membrane (or amnion) for transplantation as graft in ocular surface reconstruction is reviewed. This technique has become widespread because of the availability of the amnion, convenience and ease of use, and high and reproducible success rates. The mechanisms of action of the transplantation are varied and include the prolongation and clonogenic maintenance of epithelial progenitor cells, promotion of goblet and non-goblet cell differentiation, exclusion of inflammatory cells with anti-protease activities, suppression of Transforming Growth Factor β signaling and myoblast differentiation of normal fibroblasts. The observed clinical effects include facilitation of epithelialization, maintenance of normal phenotypes, and reduction of inflammation, vascularization and scarring. Amniotic membrane transplantation is being increasingly used as graft for various conjunctival and corneal diseases and as a patch in cases of chemical and thermal burns, refractory and recalcitrant keratitis, and most recently as an excellent substrate for expanding epithelial stem cells ex vivo.
Similar content being viewed by others
REFERENCES
Trelford, J. D. and Trelford-Sauder, M. (1979) The amnion in surgery, past and present. Am. J. Obstet. Gynecol. 134: 833–845.
de Rotth, A. (1940) Plastic repair of conjunctival defects with fetal membrane. Arch. Ophthalmol. 23: 522–525.
Brown, A. L. (1941) Lime burns of the eye: Use of rabbit peritoneum to prevent severe delayed effects. Arch. Ophthalmol. 26: 754–769.
Sorsby, A. and Symons, H. M. (1946) Amniotic membrane grafts in caustic burns of the eye. Br. J. Ophthalmol. 30: 337–345.
Sorsby, A., Haythorne, J., and Reed, H. (1947) Further experience with amniotic membrane grafts in caustic burns of the eye. Br. J. Ophthalmol. 31: 409–418.
Roper-Hall, M. J. (1965) Thermal and chemical burns. Trans. Ophthalmol. Soc. UK. 85: 631–640.
Kim, J. C. and Tseng, S. C. G. (1995) Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14: 473–484.
Dua, H. S. and Azuara-Blanco, A. (1999) Amniotic membrane transplantation. Br. J. Ophthalmol. 83: 748–752.
Fukuda, K., Chikama, T., Nakamura, M., and Nishida, T. (1999) Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea 18: 73–79.
Tseng, S. C. G., Prabhasawat, P., Barton, K., Gray, T., and Meller, D. (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch. Ophthalmol. 116: 431–441.
Lee, S.-H. and Tseng, S. C. G. (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am. J. Ophthalmol. 123: 303–312.
Kruse, F. E., Rohrschneider, K., and VÖ lcker, H. E. (1999) Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106: 1504–1511.
Chen, H.-J., Pires, R. T. F., and Tseng, S. C. G. (2000) Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br. J. Ophthalmol. 84: 826–833.
Cho, B.-J., Djalilian, A. R., Obritsch, W. F., Matteson, D. M., Chan, C. C., and Holland, E. J. (1999) Conjunctival epithelial cells cultured on human amniotic membrane fail to transdifferentiate into corneal epithelial-type cells. Cornea 18: 216–224.
Meller, D. and Tseng, S. C. G. (1999) Conjunctival epithelial cell differentiation on amniotic membrane. Invest. Ophthalmol. Vis. Sci. 40: 879–886.
Koizumi, N., Inatomi, T., Quantock, A. J., Fullwood, N. J., Dota, A., and Kinoshita, S. (2000) Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 19: 65–71.
Schwab, I. R. (1999) Cultured corneal epithelia for ocular surface disease. Trans. Am. Ophthalmol Soc. 97: 891–986.
Koizumi, N., Fullwood, N. J., Bairaktaris, G., Inatomi, T., Kinoshita, S., and Quantock, A. J. (2000) Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest. Ophthalmol. Vis. Sci. 41: 2506–2513.
Tsai, R. J. F., Li, L.-M., and Chen, J.-K. (2000) Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. New Eng. J. Med. 343: 86–93.
Prabhasawat, P. and Tseng, S. C. G. (1997) Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch. Ophthalmol. 115: 1360–1367.
Tseng, S. C. G., Li, D.-Q., and Ma, X. (1999) Suppression of Transforming Growth Factor isoforms, TGF-βreceptor II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J. Cell Physiol. 179: 325–335.
Lee, S.-B., Li, D.-Q., Tan, D. T. H., Meller, D., and Tseng, S. C. G. (2000) Suppression of TGF-β?signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr. Eye Res. 20: 325–334.
Tseng, S. C. G., Prabhasawat, P., and Lee, S.-H. (1997) Amniotic membrane transplantation for conjunctival surface reconstruction. Am. J. Ophthalmol. 124: 765–774.
Azuara-Blanco, A., Pillai, C. T., and Dua, H. S. (1999) Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol. 8339: 399–402.
Prabhasawat, P., Barton, K., Burkett, G., and Tseng, S. C. G. (1997) Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology 104: 974–985.
Shimazaki, J., Shinozaki, N., and Tsubota, K. (1998) Transplantation of amniotic membrane and limbal autograft for patients with recurrent pyterygium associated with symblepharon. Br. J. Ophthalmol. 82: 235–240.
Kim, J. C., Lee, D., and Shyn, K. H. (1997) Clinical uses of human amniotic membrane for ocular surface diseases. In: Advances in Corneal Research (J. H. Lass, ed.). Plenum Press, New York, p. 117–134.
Solomon, A., Pires, R. T. F., and Tseng, S. C. G. (2001) Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108: 449–460.
Ma, D. H.-K., See, L.-C., Liau, S.-B., and Tsai, R. J. F. (2000) Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br. J. Ophthalmol. 84: 973–978.
Choi, Y. S., Kim, J. Y., Wee, W. R., and Lee, J. H. (1998) Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea 17: 389–395.
Wang, M. X. et al. (2001) Corneal haze and apoptosis is reduced by amniotic membrane matrix in excimer laser protoablation in rabbits. J. Cat. Refract. Surg. 27: 310–319.
Park, W. C. and Tseng, S. C. G. (2000) Modulation of acute inflammation and keratocyte death by suturing, blood and amniotic membrane in PRK. Invest. Ophthalmol. Vis. Sci. 41: 2906–2914.
Koizumi, N., Inatomi, T., Sotozono, C., Fullwood, N. J., Quantock, A. J., and Kinoshita, S. (2000) Growth factor mRNA and protein in preserved human amniotic membrane. Curr. Eye Res. 20: 173–177.
Na, B. K. et al. (1999) Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis. Trophoblast Res. 13: 459–466.
Kim, J. C. and Tseng, S. C. G. The effects of inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J. Ophthalmol. 9:32–46.
Tsubota, K. et al. (1996) Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am. J. Ophthalmol. 122: 38–52.
Shimazaki, J., Yang, H.-Y., and Tsubota, K. (1997) Amniotic membrane transplantation of ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104: 2068–2076.
Tsubota, K. et al. (1999) Treatment of severe ocular surface disorders with corneal epithelial stemcell transplantation. New Eng. J. Med. 340: 1697–1703.
Tsubota, K. and Shimazaki, J. (1999) Surgical treatment of children blinded by Stevens-Johnson syndrome. Am. J. Ophthalmol. 128: 573–581.
Meller, D., Maskin, S. L., Pires, R. T. F., and Tseng, S. C. G. (2000) Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments. Cornea 19: 796–803.
Rodriguez-Ares, M. T., Tourino, R., Capeans, C., and Sanchez-Salorio, M. (1999) Repair of scleral perforation with preserved scleral amniotic membrane in Marfan's syndrome. Ophthalmic Surg. Lasers 30: 485–487.
Budenz, D. L., Barton, K., Tseng, S. C. G. (2000) Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am. J. Ophthalmol. 130: 580–588.
Pires, R. T. F. et al. (1999) Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch. Ophthalmol. 117: 1291–1297.
Kim, J. S., Kim, J. C., Na, B. K., Jeong, J. M., and Song, C. Y. (1948) Amniotic membrane patching promotes healing and inhibits protease activity on wound healing following acute corneal alkali burns. Exp. Eye Res. 70: 329–337.
Meller, D. et al. (2000) Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 107: 980–990.
John, T. (1999) Transplant successful in Stevens-Johnson syndrome: Human amniotic membrane technique treats acute damage, preserves child's eyesight. Ophthalmology Times 15: 10–13.
Kim, J. C. (1998) Use of temporary amniotic membrane graft for corneal diseases. Inaugural Scientific Meeting of Asia Pacific Society of Cornea and Refractive Surgery, 49.
Schwab, I. R., Reyes, M., and Isseroff, R. R. (2000) Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19: 421–426.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tseng, S. Amniotic Membrane Transplantation for Ocular Surface Reconstruction. Biosci Rep 21, 481–489 (2001). https://doi.org/10.1023/A:1017995810755
Issue Date:
DOI: https://doi.org/10.1023/A:1017995810755